Lung Transplantation for Pleuroparenchymal Fibroelastosis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-04-01

Study Completion Date

2021-11-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This retrospective observational study will evaluate the outcomes of lung transplantation for a rare cause of interstitial lung disease called pleuroparenchymal fibroelastosis. Data will be collected from all transplantation center in France.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Metabolic Efficiency of Combined Pancreatic Islet and Lung Transplant for the Treatment of End-Stage Cystic Fibrosis

NCT01548729

Cystic Fibrosis Diabetes Related Cystic Fibrosis Insulin-dependent Diabetes

COMPLETED PHASE1/PHASE2

Non-respiratory Comorbidities Observed in Pulmonary French Transplant Patients With Cystic Fibrosis

NCT03357913

Pulmonary Failure Cystic Fibrosis

COMPLETED

Extracorporeal Photopheresis in Patients With Bronchiolitis Obliterans Syndrome (BOS) After Lung Transplantation

NCT00502554

Bronchiolitis Obliterans

TERMINATED NA

Needs in Education for Pulmonary or Cardiopulmonary Transplanted Cystic Fibrosis Patients

NCT01285895

Cystic Fibrosis

COMPLETED

Extracorporeal Photopheresis for Medicare Recipients of Lung Allografts

NCT02181257

Bronchiolitis Obliterans Syndrome (BOS)

ACTIVE_NOT_RECRUITING PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Fibroelastosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

lung transplantation

Lung transplantation performed for end-stage interstitial lung disease secondary to pleuroparenchymal fibroelastosis.

Lung transplantation (single, lobar or bilateral lung transplantation)

Intervention Type PROCEDURE

Lung transplantation were performed for end-stage interstitial lung disease secondary to pleuroparenchymal fibroelastosis

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Lung transplantation (single, lobar or bilateral lung transplantation)

Lung transplantation were performed for end-stage interstitial lung disease secondary to pleuroparenchymal fibroelastosis

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Lung transplantation (any type) for pleuroparenchymal fibroelastosis
* Histologically confirmed pleuroparenchymal fibroelastosis on the recipient lungs

Exclusion Criteria

* All other interstitial lung disease than pleuroparenchymal fibroelastosis
* Pleuroparenchymal fibroelastosis who didn't underwent lung transplantation

Eligible Sex

ALL

Accepts Healthy Volunteers

No